AI-generated summary
This review describes proposed mechanisms of low-level light therapy using red to near-infrared light on the eye and brain, centered on cytochrome oxidase and mitochondrial function. The authors report benefits in retinal disease, stroke, neurotrauma, neurodegeneration, and memory and mood disorders, including increased cerebral blood flow and cognitive effects in humans. The abstract does not present a count of included studies or participants.
- Who or what was studied
- Not specified; the review covers retinal, brain, and general nervous tissue research, including some human data.
- Limits stated in the abstract
- The abstract does not report the number of included studies, participants, or the strength of the evidence behind the stated benefits.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on dovepress.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Near-infrared, Cerebral blood flow, Dosimetry, Retina, Stroke. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.